- £1.86bn
- £911.28m
- $548.51m
- 32
- 42
- 45
- 29
Annual balance sheet for HUTCHMED (China), fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,013 | 632 | 886 | 836 | 1,367 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 149 | 129 | 153 | 172 | 151 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 1,212 | 840 | 1,097 | 1,067 | 1,567 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 53.2 | 84.7 | 104 | 97 | 97.7 |
| Net Goodwill | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,373 | 1,029 | 1,280 | 1,274 | 1,753 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 312 | 354 | 403 | 377 | 316 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 386 | 419 | 549 | 514 | 515 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 987 | 610 | 731 | 760 | 1,238 |
| Total Liabilities & Shareholders' Equity | 1,373 | 1,029 | 1,280 | 1,274 | 1,753 |
| Total Common Shares Outstanding |